ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,948Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 2170

$1.72M Total Retail Price of All Prescriptions

Rank: 15 out of 2170

848 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 848 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 848 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 27,112 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
FUROSEMIDE 1,151 1,056 1 6
WARFARIN SODIUM 1,038 932 2 15
LEVOTHYROXINE SODIUM 911 820 3 5
OMEPRAZOLE 843 728 4 2
NAMENDA 815 800 5 48
CITALOPRAM HBR 750 705 6 19
LISINOPRIL 738 669 7 3
MIRTAZAPINE 715 697 8 46
DONEPEZIL HCL 693 681 9 32
AMLODIPINE BESYLATE 660 617 10 4
METOPROLOL TARTRATE 561 524 11 10
POTASSIUM CHLORIDE 545 498 12 16
GABAPENTIN 525 466 13 14
SIMVASTATIN 525 462 13 1
CYMBALTA 455 417 15 44
HYDROCODONE-ACETAMINOPHEN 421 402 S3 16 7
POLYETHYLENE GLYCOL 3350 399 341 17 63
LANTUS 394 360 18 51
OXYCODONE HCL 332 304 S2 19 56
METOPROLOL SUCCINATE 310 293 20 13
LAMOTRIGINE 301 290 21 136
DIVALPROEX SODIUM 296 252 22 91
ATORVASTATIN CALCIUM 287 263 23 12
SERTRALINE HCL 274 243 24 25
TRAMADOL HCL 259 244 25 18
DIGOXIN 237 221 26 72
QUETIAPINE FUMARATE 228 206 27 88
TAMSULOSIN HCL 228 200 27 33
LOSARTAN POTASSIUM 212 202 29 21
TRAZODONE HCL 211 204 30 38
ZOLPIDEM TARTRATE 208 195 31 17
DILTIAZEM 24HR CD 207 207 32 82
NOVOLOG 204 173 33 98
KLOR-CON M20 197 181 34 68
SPIRIVA 195 176 35 49
OXYCODONE-ACETAMINOPHEN 191 175 S2 36 60
ADVAIR DISKUS 191 179 36 45
LEVOFLOXACIN 188 175 38 99
ALBUTEROL SULFATE 188 124 38 167
LEVETIRACETAM 187 133 40 109
CEPHALEXIN 186 174 41 120
ESCITALOPRAM OXALATE 177 165 42 75
ATENOLOL 177 163 42 23
ISOSORBIDE MONONITRATE ER 165 164 44 50
CLOPIDOGREL 162 162 45 37
RANITIDINE HCL 161 146 46 40
SPIRONOLACTONE 157 145 47 71
ALENDRONATE SODIUM 157 133 47 36
PANTOPRAZOLE SODIUM 156 149 49 39
IPRATROPIUM-ALBUTEROL 155 143 50 131
CARBIDOPA-LEVODOPA 155 155 50 110
PREDNISONE 153 130 52 41
CARVEDILOL 152 142 53 26
ALLOPURINOL 150 126 54 29
RISPERIDONE 150 148 54 73
HYDROCHLOROTHIAZIDE 150 148 54 9
PROMETHAZINE HCL 146 130 R 57 70
FENTANYL 146 127 S2 57 87
LIDODERM 145 142 59 162
EXELON 142 130 60 119
GLIMEPIRIDE 139 139 61 31
METFORMIN HCL 137 134 62 8
ROPINIROLE HCL 125 120 63 92
CLONIDINE HCL 123 119 64 54
SULFAMETHOXAZOLE-TRIMETHOPRIM 120 112 65 95
CIPROFLOXACIN HCL 119 111 66 69
PLAVIX 112 109 67 58
DIOVAN 109 93 68 53
TRAVATAN Z 109 109 68 181
VENLAFAXINE HCL ER 108 91 70 97
AMOX TR-POTASSIUM CLAVULANATE 108 100 70 126
HUMALOG 107 102 72 190
NYSTATIN 107 106 72 160
LACTULOSE 107 58 72 125
BACLOFEN 105 30 75 137
SUCRALFATE 104 93 76 197
NITROFURANTOIN 104 92 76 270
CEFTRIAXONE 100 95 78 211
LIDOCAINE HCL 99 95 79 238
OXYBUTYNIN CHLORIDE ER 95 76 80 148
RESTASIS 94 94 81 233
LYRICA 90 88 82 90
CYCLOBENZAPRINE HCL 88 82 R 83 52
DIVALPROEX SODIUM ER 87 80 84 189
NOVOLIN R 86 86 85 149
KLOR-CON M10 83 68 86 132
SEROQUEL 82 76 87 168
FLUOXETINE HCL 81 53 88 59
LATANOPROST 81 76 88 194
DOXYCYCLINE HYCLATE 76 61 90 100
FINASTERIDE 76 72 90 122
AMOXICILLIN 75 68 92 114
AZITHROMYCIN 75 70 92 47
PHENYTOIN SODIUM EXTENDED 74 40 94 142
NITROFURANTOIN MONO-MACRO 71 68 95 196
NITROGLYCERIN PATCH 71 71 95 232
IPRATROPIUM BROMIDE 69 46 97 239
ABILIFY 67 52 98 159
FLUTICASONE PROPIONATE 67 45 98 30
DILTIAZEM HCL 65 63 100 224
CELEBREX 65 51 100 89
FAMOTIDINE 63 55 102 96
TERAZOSIN HCL 63 63 102 156
OXYCONTIN 61 60 S2 104 146
HALOPERIDOL 60 54 105 176
MELOXICAM 60 60 105 28
SINGULAIR 60 57 105 85
CLONIDINE 59 58 108 263
LEXAPRO 59 53 108 198
PATANOL 57 46 110 339
LEVEMIR 57 55 110 195
PRAVASTATIN SODIUM 56 54 112 11
HYDRALAZINE HCL 56 56 112 84
PREMARIN 56 31 R 112 145
ONDANSETRON HCL 55 52 115 230
NYSTOP 55 54 115 219
MORPHINE SULFATE ER 53 46 S2 117 124
PAROXETINE HCL 52 41 118 65
HYDROXYZINE HCL 52 52 R 118 173
AGGRENOX 52 39 118 169
NEXIUM 51 45 121 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.